|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 62.25 EUR | +0.65% |
|
+4.01% | -1.11% |
| Nov. 18 | Rovi and Roche sign final agreement for manufacture of new medicine | RE |
| Nov. 06 | Spanish stocks - Factors to watch on Nov 6 | RE |
Chart calendar Laboratorios Farmaceuticos Rovi, S.A.
Upcoming events on Laboratorios Farmaceuticos Rovi, S.A.
| 2026-03-02 | Q4 2025 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
| 2026-05-12 | Q1 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
| 2026-07-28 | Q2 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
| 2026-11-04 | Q3 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
Past events on Laboratorios Farmaceuticos Rovi, S.A.
| 2025-11-05 | Q3 2025 Earnings Call |
| 2025-11-05 | Q3 2025 Earnings Release |
| 2025-07-24 | Q2 2025 Earnings Call |
| 2025-07-23 | Q2 2025 Earnings Release |
| 2025-07-13 | Ex-dividend day for final dividend |
| 2025-06-19 | Annual General Meeting - Second Call |
| 2025-06-18 | Annual General Meeting - First Call |
| 2025-05-07 | Q1 2025 Earnings Call |
| 2025-05-07 | Q1 2025 Earnings Release |
| 2025-03-25 | Capital Market Day |
| 2025-03-19 | KeyBanc Healthcare Forum |
| 2025-02-25 | Q4 2024 Earnings Call |
| 2025-02-24 | Q4 2024 Earnings Release |
| 2024-11-07 | Q3 2024 Earnings Call |
| 2024-11-06 | Q3 2024 Earnings Release |
| 2024-07-31 | Q2 2024 Earnings Call |
| 2024-07-30 | Q2 2024 Earnings Release |
| 2024-07-07 | Ex-dividend day for final dividend |
| 2024-05-07 | Q1 2024 Earnings Call |
| 2024-05-07 | Q1 2024 Earnings Release |
Past dividends on Laboratorios Farmaceuticos Rovi, S.A.
| 2025-07-13 | Annual 0.757431 EUR |
| 2024-07-07 | Annual 0.893997 EUR |
| 2023-07-02 | Annual 1.047978 EUR |
| 2022-07-04 | Annual 0.774036 EUR |
| 2021-07-04 | Annual 0.308772 EUR |
| 2020-11-16 | Annual 0.141831 EUR |
| 2019-07-01 | Annual 0.064638 EUR |
| 2018-07-02 | Annual 0.097767 EUR |
| 2017-07-02 | Annual 0.14823 EUR |
| 2016-06-29 | Annual 0.11259 EUR |
| 2015-07-01 | Annual 0.1352 EUR |
| 2014-07-02 | Annual 0.127348 EUR |
| 2013-07-02 | Annual 0.107914 EUR |
| 2012-07-03 | Annual 0.100251 EUR |
| 2011-07-05 | Annual 0.1393848 EUR |
| 2010-07-05 | Annual 0.11421 EUR |
| 2009-07-07 | Final Payment 0.07093 EUR |
| 2008-09-16 | Interim Payment 0.0642 EUR |
Annual results
| Fiscal Period | December | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 818 788 3.78% | 830 823 0.79% | 764 765 -0.15% | 723 | 807 | 969 |
|
EBITDA Million EUR | Released Forecast Spread | 279 252 10.47% | 245 239 2.36% | 207 219 -5.33% | 189 | 237 | 304 |
|
EBIT Million EUR | Released Forecast Spread | 256 230 11.48% | 220 214 2.67% | 179 188 -4.75% | 159 | 205 | 270 |
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | 258 226 14.07% | 220 217 1.8% | 178 195 -8.75% | 158 | 191 | 269 |
|
Net income Million EUR | Released Forecast Spread | 200 183 9.36% | 170 167 2.05% | 137 146 -6.1% | 124 | 159 | 210 |
|
EPS EUR | Released Forecast Spread | 3,73 3,35 11.19% | 3,20 3,12 2.58% | 2,67 2,81 -4.87% | 2,42 | 3,16 | 4,21 |
| Announcement Date | 21/02/23 | 27/02/24 | 25/02/25 | - |
Quarterly results
| Fiscal Period | June | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 S1 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 S1 | 2025 Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 235 226 3.91% | 151 154 -1.55% | 178 175 2.1% | 329 327 0.81% | 235 230 2.39% | 199 194 2.64% | 155 150 3.04% | 160 158 0.78% | 315 310 1.38% | 210 210 0.45% |
|
EBITDA Million EUR | Released Forecast Spread | 73,3 71,1 3.14% | 25,9 26,3 -1.33% | 44,0 39,7 10.9% | 69,9 67,7 3.25% | 97,3 83,5 16.56% | 40,2 38,1 5.58% | 30,3 26,2 15.56% | 35,3 31,8 10.95% | 65,6 61,8 6.15% | 83,9 81,4 3.13% |
|
EBIT Million EUR | Released Forecast Spread | 66,7 66,0 1.06% | 19,3 20,6 -6.18% | 37,2 32,4 14.76% | 56,5 54,5 3.63% | 90,1 79,5 13.36% | 32,8 34,0 -3.42% | 23,0 18,4 24.88% | 27,9 23,8 17.34% | 50,9 47,0 8.51% | 76,3 75,2 1.44% |
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | 19,0 19,8 -4% | |||||||||
|
Net income Million EUR | Released Forecast Spread | 51,5 47,7 8.04% | 15,0 11,9 25.37% | 29,4 26,2 12.05% | 44,3 41,9 5.84% | 69,1 59,3 16.61% | 23,4 24,7 -5.21% | 18,1 15,2 18.82% | 21,6 20,0 8.18% | 39,7 38,0 4.57% | 58,0 59,0 -1.65% |
| Announcement Date | 27/02/24 | 08/05/24 | 31/07/24 | 31/07/24 | 07/11/24 | 25/02/25 | 08/05/25 | 23/07/25 | 23/07/25 | 06/11/25 |
| 2026-01-05 | Q3 2025 Earnings Release | Add to your calendar Google Apple ICS format | |
| 2026-01-11 | Q2 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format | |
| 2026-01-15 | Q3 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format | |
| 2026-01-20 | Q4 2025 Earnings Release | Add to your calendar Google Apple ICS format | |
| 2026-01-20 | Q4 2025 Earnings Release (Projected) | Add to your calendar Google Apple ICS format | |
| 2026-01-21 | Q3 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format | |
| 2026-01-21 | Q3 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format | |
| 2026-01-21 | Q3 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format | |
| 2026-01-22 | Q3 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format | |
| 2026-01-26 | Q3 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
Past sector events for Laboratorios Farmaceuticos Rovi, S.A.
| 2025-12-10 | November 2025 Sales and Revenue Release | |
| 2025-12-10 | November 2025 Sales and Revenue Release | |
| 2025-12-09 | Q2 2026 Earnings Release | |
| 2025-12-09 | November 2025 Sales and Revenue Release | |
| 2025-12-09 | November 2025 Sales and Revenue Release | |
| 2025-12-05 | November 2025 Sales and Revenue Release | |
| 2025-11-30 | Q3 2025 Earnings Release | |
| 2025-11-27 | Q2 2026 Earnings Release | |
| 2025-11-19 | Q3 2025 Earnings Release | |
| 2025-11-14 | Q2 2026 Earnings Release |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ROVI Stock
- Calendar Laboratorios Farmaceuticos Rovi, S.A.
Select your edition
All financial news and data tailored to specific country editions
















